3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Retinal Diseases in 3 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
Retinal Diseases: Diseases involving the RETINA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeNiro, M | 3 |
| Al-Halafi, A | 1 |
| Al-Mohanna, FH | 2 |
| Alsmadi, O | 1 |
| Al-Mohanna, FA | 3 |
3 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Retinal Diseases
| Article | Year |
|---|---|
Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Indazoles; Mice; Mice, Inbred C57BL; Neovasculari | 2010 |
Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy.
Topics: Animals; Blotting, Western; Cell Line; Cell Movement; Cell Proliferation; Cells, Cultured; Fluoresce | 2011 |
Zinc transporter 8 (ZnT8) expression is reduced by ischemic insults: a potential therapeutic target to prevent ischemic retinopathy.
Topics: Animals; Cation Transport Proteins; Cell Line; Enzyme Activators; Gene Expression Regulation; Hypoxi | 2012 |